Stock GLENMARK GLENMARK PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Glenmark Pharmaceuticals Limited

Equities

GLENMARK

INE935A01035

Market Closed - NSE India S.E.
Other stock markets
 07:43:52 2024-05-31 am EDT 		5-day change 1st Jan Change
1,160 INR +0.38% Intraday chart for Glenmark Pharmaceuticals Limited +12.00% +35.88%
May. 29 Assertio Therapeutics Names Brendan O'Grady as Chief Executive MT
May. 28 INDIA STOCKS-Metal stocks lead Indian shares higher RE

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Glenmark Pharmaceuticals : Investors Day 2024
PU
Assertio Therapeutics Names Brendan O'Grady as Chief Executive
MT
Glenmark Pharmaceuticals : Q4FY 2023-24
PU
INDIA STOCKS-Metal stocks lead Indian shares higher
RE
Glenmark Pharmaceuticals Widens Consolidated Net Loss in Fiscal Q4
MT
Glenmark Pharmaceuticals : Q4 FY 2023-24
PU
INDIA STOCKS-Indian shares at record highs, boosted by pharma stocks, Adani Ports
RE
Glenmark Pharmaceuticals Limited Provides Earnings Guidance for the Fiscal Year 2025
CI
Transcript : Glenmark Pharmaceuticals Limited, Q4 2024 Earnings Call, May 27, 2024
Glenmark Pharmaceuticals : Pharma Reports Q4 FY2023-24 Financial results
PU
Glenmark Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
CI
Glenmark Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024
CI
Glenmark Pharmaceuticals Limited Recommends Dividend for the Financial Year 2023-24
CI
India's Sensex Ends Down, Nifty Up Ahead of National Poll Outcome
MT
Glenmark Pharma Arm to Market Two Beigene Cancer Drugs in India
MT
Glenmark Pharmaceuticals receives ANDA approval for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, 0.2%|0.5%
AQ
Glenmark Pharmaceuticals Receives ANDA Approval for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, 0.2%|0.5%
CI
Glenmark Pharmaceuticals : receives ANDA approval for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, 0.2%|0.5%
PU
Glenmark Pharmaceuticals to Acquire 26% Stake in Renewable Energy Company
MT
Glenmark Pharmaceuticals Limited Appoints Shweta Munjal as Chief Communications & CSR Officer
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GLENMARK Stock
  4. News Glenmark Pharmaceuticals Limited